Filing metadata

Accession number
0001493152-22-032557
Form type
Form 4
Filer
Immix Biopharma, Inc.
CIK
CIK 1873835
Filed
Nov 15, 2022
Reporting period
Nov 14, 2022
Description
Insider transaction

Explore SEC Filings Hub